Phesi celebrates 100 million global patient data milestone
Phesi’s artificial intelligence (AI) driven platform, Trial Accelerator, has reached a milestone and now contains global data from more than 100 million patients.
Jonathan Peachey Gen Li Japanese Patent Office For Phesi Trial Accelerator Digital Patient Profile Refractory Follicular Lymphoma
Source: outsourcing-pharma.com